These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists. Ali SM, Tedford CE, Gregory R, Handley MK, Yates SL, Hirth WW, Phillips JG. J Med Chem; 1999 Mar 11; 42(5):903-9. PubMed ID: 10072687 [Abstract] [Full Text] [Related]
8. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain. Pelloux-Léon N, Fkyerat A, Piripitsi A, Tertiuk W, Schunack W, Stark H, Garbarg M, Ligneau X, Arrang JM, Schwartz JC, Ganellin CR. J Med Chem; 2004 Jun 03; 47(12):3264-74. PubMed ID: 15163206 [Abstract] [Full Text] [Related]
9. [125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor. Stark H, Purand K, Hüls A, Ligneau X, Garbarg M, Schwartz JC, Schunack W. J Med Chem; 1996 Mar 15; 39(6):1220-6. PubMed ID: 8632428 [Abstract] [Full Text] [Related]
10. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA. J Pharmacol Exp Ther; 2005 Jul 15; 314(1):271-81. PubMed ID: 15821027 [Abstract] [Full Text] [Related]
17. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects. Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA. J Pharmacol Exp Ther; 2003 Jun 01; 305(3):887-96. PubMed ID: 12606603 [Abstract] [Full Text] [Related]